Moderna Inc
Oil prices top $100, FDA leadership change, the wellness boom and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning. If you’re getting on a plane soon, consider this a public service announcement that you may want to give yourself extra time for security lines. Stock futures are tanking this morning following a losing week on Wall Street. Here are […]
Read More
FDA vaccine head will step down in April after string of controversial decisions
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]
Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration. The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]
Read More
Stocks making the biggest moves premarket: Moderna, Ross Stores, Box, Gitlab and more
Check out the companies making headlines before the bell. Moderna — The biotechnology firm’s stock rose nearly 11% after it said it agreed to pay up to $2.25 billion to settle with Biopharma Corporation and Genevant Sciences GmbH a lawsuit over a Covid vaccine patent dispute. Ross Stores — Shares popped 7% after the off-price […]
Read More
AI disruption didn’t show up in Salesforce results. But the fears are hard to shake
Salesforce on Wednesday evening delivered better-than-expected 2026 fourth-quarter results as its Agentforce artificial intelligence platform became increasingly embedded across the business. However, the stock dropped in after-hours trading as investors remained anxious about the potential of AI disrupting traditional enterprise software companies. Revenue in the quarter ended Jan. 31 rose 12% year over year to […]
Read More
Walmart earnings, Fed meeting minutes, Zuckerberg’s testimony and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Thursday. My spin class soundtrack of mainly Kesha’s music last night was more evidence that the 2016 aesthetic is back. Stock futures are lower this morning. The three major indexes are coming off a winning session. Here are five key things […]
Read More
FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal
A researcher works in the lab at the Moderna headquarters in Cambridge, Massachusetts, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna said on Wednesday the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing the agency’s earlier decision to refuse to accept the application in a move […]
Read More
Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more
Check out the companies making headlines in midday trading: Acadia Healthcare — The health-care stock popped 10% after investor David Einhorn told CNBC that he has been buying the stock. The Greenlight Capital fund manager said he’s hopeful the company’s new management will be able to improve its performance. Vertiv — The provider of data […]
Read More
January’s jobs report, Ford earnings, Epstein fallout and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning, and happy jobs Wednesday. We may have had to wait five extra days for January’s nonfarm payrolls report, but at least we’ve had the Winter Olympics to pass the time. Norway currently leads with six gold medals, while the U.S. […]
Read More
Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more
Check out the companies making headlines before the bell: Moderna — Shares tumbled 10% after the pharma giant said the Food and Drug Administration refused to review its application for an experimental flu shot, mRNA-1010. Moderna said it has requested a meeting with the FDA to “understand the path forward.” Humana — The health insurance company […]
Read More